RVPH

Reviva Pharmaceuticals Holdings, Inc.

3.83 USD
-0.04 (-1.03%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Reviva Pharmaceuticals Holdings, Inc. stock is down -4.73% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 February’s closed higher than January. In the last 1 Unusual Options Trades, there were 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
29 Jan 17:24 17 Jan, 2025 10.00 PUT 48 202

About Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia. RP1208 that is in pre-clinical development studies for depression and obesity.